Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Experimental robot car in Tokyo is driven by moths in search of a date

Add as a preferred source on Google

No, it’s not a wacky Japanese game show, folks, scientists at the University of Tokyo’s Research Center for Advanced Science and Technology really have built a robot car which can be controlled by silkworm moths in their quest to find an attractive mate. Picture the Pimp My Ride of the lepidopteran world — only with labcoat-wearing scientists playing the Xzibit role!

The work involved getting moths to walk over an air-supported ball treadmill in pursuit of female silkworm pheromones. The vehicle built by the scientists follows the movement of the ball by way of optical sensors and then drives in that direction.

Recommended Videos

As it turned out, the moths were reasonably proficient drivers, too. In seven trials with seven drivers, the insects were able to drive the car to their targets almost as efficiently as they would by walking — arriving just two seconds behind the walking moths.

But what is a scent-driven robot moth car actually useful for? Quite a lot, it turns out. “Our goal is to understand the mechanism behind insect adaptive behaviors,” researcher Noriyasu Ando told Digital Trends. “We have two usages regarding this robot: One is for engineering and the other is for biology.”

The engineering use for this robot car is in the interests of developing artificial systems based on biological principles — in this case a robot that could turn biological inputs (sense of smell) into control mechanisms.

From a biological perspective, the work can help uncover details of the insect brain. “We can employ this ‘hybrid’ robot as an experimental tool for understanding the mechanism behind insect adaptive behavior,” Ando continued. “If we regard the insect-controlled robot as a single organism, the robot part is implemented in the closed-loop of the sensory-motor system of this hybrid organism. This point is beneficial for biologists because we can easily, reversibly and non-invasively alter the sensory-motor properties of the organism.”

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more